Don’t forget to join us: escardio.org/Councils/Counci… Membership is free - a multidisciplinary Council, with interested colleagues in heart-brain interactions #collaboration with scientific initiatives, position papers, translational science, webinars, blogs tinyurl.com/532ur22n

Llevas años sumando factores de riesgo como si todos pesaran lo mismo. El registro GLORIA-AF acaba de poner números a esa suposición. 🧮 Una escala ponderada de 10 factores, de 0 a 23 puntos, derivada en 20.517 pacientes con fibrilación auricular de nuevo diagnóstico. ⚖️ La tromboembolia previa vale 5 puntos y la hiperlipidemia 1. El CHA2DS2-VA les da 2 y 0 respectivamente. 📈 Índice C de 0,661 frente a 0,626 del CHA2DS2-VA en derivación, y 0,652 frente a 0,616 en validación externa. 🔍 La mejora en reclasificación de los pacientes que sí sufren el ictus no se reproduce fuera de la cohorte donde nació la escala. ⚠️ Ojo con la función renal: los 4 puntos son para diálisis, trasplante o creatinina ≥ 2,26 mg/dL, no para cualquier enfermedad renal crónica. 🩺 Los propios autores lo dicen: complemento del CHA2DS2-VA, no sustituto, y ningún umbral validado para decidir anticoagulación. cardioteca.com/arritmias/851…

📍AFFIRMO research on display at #EuGMS2026! AFFIRMO's presence at the EuGMS Congress 2026 also included a dedicated stand, providing an opportunity to share our research, connect with researchers and healthcare professionals, and exchange ideas. #AFFIRMO #Multimorbidity

🎙️Listen to our latest #CardioTalkStroke Podcast! @JacopoImberti & prof. Y. Guo discuss on wearables, risk scoring, and ECG: from evidence to implementation Available on all your favorite apps! 🖇️tinyurl.com/a7f9uyfy @GiulioFRomiti @Fra_Vitali90 @escardio @EHRAPresident

Huge congratulations to the whole team @PolishSmog — @ESCStrokeChair @AnnaKurasz_ and Sławomir Dobrzycki — for winning the award for the Best Original Research presented at the @PTKardio Congress! 🏆👏 A fantastic recognition of our collaborative work! ❤️

🎓PhD Opportunity: HEART–MIND AF ♥️🧠 🗓️ Deadline: 13th October 2026 @ 1pm ✉️ Contact @BuckleyBenjamin to discuss #PhD #NIHR #ARCNWC #AtrialFibrillation #MentalHealth #CardiovascularHealth #HealthInequalities #CoDesign

Cardiologists' tools learned in med school dominate (CHA2DS2-VA 85%, HAS-BLED 77%). Nephrology-specific tools lag despite clinical need (KFRE 39%, IgAN 33%, ADPKD MIC 26%). Disease-specific tools concentrate in academic centers; community settings rarely use them.

Post AF Ablation Anticoagulation: Real World Practice and Predictors of Therapy #OpenAccess @EmilyZeitler heartrhythmjournal.com/artic…

What is the optimal antithrombotic strategy after LAAO? In this large real-world analysis, reduced-dose DOAC and SAPT were associated with more favourable outcomes than DAPT, while reduced-dose DOAC showed no clear advantage over SAPT—supporting simplified, individualised post-LAAO management. eurointervention.pcronline.c… #LAAO #AntithromboticTherapy #AtrialFibrillation

A great close to #AFFIRMO! 🎉 Our Final Conference brought together experts and European projects for rich discussions on integrated, personalised care, multimorbidity and the responsible use of AI. A strong step towards more patient-centred healthcare. ❤️ #DigitalHealth #AI

🎙️ Editor's Choice Podcast is back! Dr Aaysha Cader (@aayshacader) is joined by Professor Gregory Lip to discuss antithrombotic strategies after left atrial appendage occlusion. 🫀 Reduced-dose DOAC, DAPT or SAPT? They explore the clinical outcomes and why reduced-dose DOAC may offer mechanistic advantages over antiplatelet therapy. 🎧 Listen to the new episode: eurointervention.pcronline.c… 📖 Read the Original Research: eurointervention.pcronline.c… #InterventionalCardiology #CardioEducation #LAAO #DAPT #SAPT

Reduced-dose direct oral anticoagulant versus antiplatelet strategies after left atrial appendage occlusion: Original Research • EuroIntervention | Editor's Choice open.spotify.com/episode/1tb…

There’s still time to submit your abstract to ESC Heart & Stroke 2026 – EuroThrombosis 2026, taking place in Prague, Czechia on 13-14 November ow.ly/rB4M50ZLbYz ⏰ The deadline has just been extended to Monday, 14 September ⏰ If your abstract is considered one of the best, you’ll be selected to present it. When you submit on the online platform, you can also apply for a travel grant. This joint meeting will bring together leading clinicians, researchers, and allied healthcare professionals from across Europe and beyond to share the latest advances in stroke and thrombosis research. Submit now and be one of them! @ESCWGThrombosis @ESCStrokeChair #ESCStroke #ESCHeartAndStroke #EuroThrombosis

Can LAAC replace DOACs for #stroke prevention in #AFib? New in #JACCAdvances: This meta-analysis of randomized trials found LAAC reduced nonprocedure-related bleeding but may come at the cost of a higher risk of ischemic stroke. jacc.org/doi/10.1016/j.jacad… #NOAC #cvLAAOccluder

📍 Aalborg University, Copenhagen | The AFFIRMO partners are meeting for the project's final consortium meeting. Each partner is presenting the results of the past 5 years including the clinical trials run in 🇮🇹 🇧🇬 🇩🇰 🇷🇴 🇷🇸 🇪🇸 Stay tuned for next updates #AFFIRMO #EUresearch

📢 Good news – abstract submission deadline extended! 🆕 New abstract submission deadline: 14 September 2026 Accepted abstracts will be published in EHJ-Supplements! Join us in Prague, 13–14 November 2026 🔗esc365.escardio.org/event/22… @escardio @LiverpoolCCS @JacopoImberti

Atrial fibrillation is the most common heart rhythm disorder in the world. That was the starting point of a coffee morning, half an hour answering questions from patients☕️💜 Click the link and discover the video piped.video/P2YZdBSZdpE

Direct oral anticoagulants vs dual antiplatelet therapy following left atrial appendage closure in atrial fibrillation heartrhythmjournal.com/artic…

Hovedresultaterne fra AFFIRMO er klar - Aalborg Universitet @affirmo_eu @TARGET_horizon @ARISTOTELES_HE klinisk.aau.dk/hovedresultat…

AFFIRMO was at #ESCCongress2026 in Munich 🇩🇪 Prof. Gregory Lip, Prof. Deidre Lane and Prof. Davide L. Vetrano presented AFFIRMO's results and findings at the Congress. Read more affirmo.eu/news/affirmo-at-e… #AtrialFibrillation #Multimorbidity

Great to present at #ESC2026 two my concepts: 'ePM-years Index' and SENTINEL EXPOSOME — moving environmental cardiology from evidence to action. @PolishSmog @ESCStrokeChair Exposure → risk → action.